Literature DB >> 19995140

The added burden of comorbidity in patients with asthma.

Tingting Zhang1, Bruce C Carleton, Robert J Prosser, Anne M Smith.   

Abstract

OBJECTIVE: Compare the prevalence of comorbidities in adults with and without asthma in Canada and investigate the association between comorbidities in patients with asthma and the occurrence of asthma symptoms or attacks.
METHODS: Survey data from the 2005 Canadian Community Health Survey (CCHS) were analyzed. A total of 132,221 Canadians participated in the national survey; 10,089 adult respondents from 10 Canadian provinces and 3 territories reported having asthma. Analyses focused on 11 major chronic comorbidities.
RESULTS: Respondents with asthma were more likely to have comorbidities except cancer; 31% of respondents with asthma and comorbidities reported their health status to be fair or poor. For respondents with asthma, non-asthma chronic respiratory disease, mental illness, and allergy were significantly associated with having asthma symptoms or attacks.
CONCLUSIONS: Many Canadians with asthma report a high comorbidity burden. These patients will likely require more health services and more complex health management strategies. Comorbid conditions should be clearly identified with particular emphasis on management of mood disorders and anxiety because these conditions are likely to increase asthma symptomatology and may be unrecognized by clinicians.

Entities:  

Mesh:

Year:  2009        PMID: 19995140     DOI: 10.3109/02770900903350473

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  24 in total

1.  An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

Authors:  Gwen S Skloot; Paula J Busse; Sidney S Braman; Elizabeth J Kovacs; Anne E Dixon; Carlos A Vaz Fragoso; Nicola Scichilone; Y S Prakash; Christina M Pabelick; Sameer K Mathur; Nicola A Hanania; Wendy C Moore; Peter G Gibson; Susan Zieman; Betina B Ragless
Journal:  Ann Am Thorac Soc       Date:  2016-11

2.  Does the healthy immigrant effect extend to anxiety disorders? Evidence from a nationally representative study.

Authors:  Mary Aglipay; Ian Colman; Yue Chen
Journal:  J Immigr Minor Health       Date:  2013-10

3.  Neuropsychiatric adverse effects of montelukast in children.

Authors:  Pierre Ernst; Geneviève Ernst
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

4.  Asthma and proinflammatory conditions: a population-based retrospective matched cohort study.

Authors:  Hyun D Yun; Erin Knoebel; Yilma Fenta; Sherine E Gabriel; Cynthia L Leibson; Edward V Loftus; Veronique Roger; Barbara P Yawn; Bill Li; Young J Juhn
Journal:  Mayo Clin Proc       Date:  2012-09-12       Impact factor: 7.616

5.  Analysis of the relation between level of asthma control and depression and anxiety.

Authors:  Hanna Trzcińska; Grzegorz Przybylski; Bartosz Kozłowski; Sebastian Derdowski
Journal:  Med Sci Monit       Date:  2012-03

6.  Comorbid diseases in adult asthma.

Authors:  Young-Koo Jee
Journal:  Allergy Asthma Immunol Res       Date:  2012-12-12       Impact factor: 5.764

7.  Diseases concomitant with asthma in middle-aged and elderly subjects in Korea: a population-based study.

Authors:  Jinkyeong Park; Tae-Bum Kim; Hyejin Joo; Jae Seoung Lee; Sang Do Lee; Yeon-Mok Oh
Journal:  Allergy Asthma Immunol Res       Date:  2012-07-25       Impact factor: 5.764

8.  Influence of asthma epidemiology on the risk for other diseases.

Authors:  Young J Juhn
Journal:  Allergy Asthma Immunol Res       Date:  2012-01-27       Impact factor: 5.764

9.  Modifying effect of suicidal ideation on the relationship between asthma and cigarette use behaviors among Korean adolescents.

Authors:  Jisuk Bae; Eun Young Park; Soon Woo Park
Journal:  J Prev Med Public Health       Date:  2011-05

10.  Describing and quantifying asthma comorbidity [corrected]: a population study.

Authors:  Andrea S Gershon; Jun Guan; Chengning Wang; J Charles Victor; Teresa To
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.